Natural History and Outcomes of Asymptomatic IgM Monoclonal Gammopathy

被引：0
|
作者：
Kastritis, Efstathios
Kanellias, Nikolaos
Gavriatopoulou, Maria
Eleutherakis-Papaiakovou, Evangelos
Roussou, Maria
Papathoma, Alexandra
Panagiotidis, Ioannis
Migkou, Magdalini
Fotiou, Despina
Ziogas, Dimitrios C.
Ntanasis-Stathopoulos, Ioannis
Spyropoulou-Vlachou, Marilyn
Tasidou, Anna
Terpos, Evangelos
Dimopoulos, Meletios A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1882
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Factors Predicting Transformation of Asymptomatic IgM Monoclonal Gammopathy
    Greco, Antonino
    Tedeschi, Alessandra
    Varettoni, Marzia
    Nichelatti, Michele
    Paris, Laura
    Ricci, Francesca
    Vismara, Eleonora
    Morra, Enrica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01): : 77 - 79
  • [2] Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy
    Morra, E
    Cesana, C
    Klersy, C
    Varettoni, M
    Cavanna, L
    Canesi, B
    Tresoldi, E
    Barbarano, L
    Lazzarino, M
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 172 - 177
  • [3] RELEVANCE OF THE BONE MARROW ASPIRATION IN THE CLASSIFICATION AND FORECAST OF THE IGM ASYMPTOMATIC MONOCLONAL GAMMOPATHY
    Moreno, D. F.
    Tovar, N.
    Cibeira, M. T.
    Isola, I.
    Magnano, L.
    Lopez Guerra, M.
    Colomer, D.
    Diaz, T.
    Rodriguez Lobato, L. G.
    Oliver, A.
    Lozano, E.
    Rosinol, L.
    Blade, J.
    Fernandez de Larrea, C.
    HAEMATOLOGICA, 2019, 104 : 141 - 141
  • [4] Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
    Moreno, David F.
    Pereira, Arturo
    Tovar, Natalia
    Cibeira, Maria Teresa
    Magnano, Laura
    Rozman, Maria
    Lopez-Guerra, Monica
    Colomer, Dolors
    Martin-Antonio, Beatriz
    Jimenez-Segura, Raquel
    Isola, Ignacio
    Rodriguez-Lobato, Luis Gerardo
    Oliver-Caldes, Aina
    Mena, Mari Pau
    Rosinol, Laura
    Blade, Joan
    Fernandez de Larrea, Carlos
    CANCERS, 2021, 13 (09)
  • [5] Anti-MAG IgM antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy
    Meucci, N
    Baldini, L
    Barbieri, S
    DiTroia, A
    Cappellari, A
    Allaria, S
    Scarlato, G
    NobileOrazio, E
    NEUROLOGY, 1997, 48 (03) : 1085 - 1085
  • [6] Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
    Morra, E
    Cesana, C
    Klersy, C
    Varattoni, M
    Cavanna, L
    Canesi, B
    Tresoldi, E
    Miqueleiz, S
    Nosari, A
    Barbarano, L
    Lazzarino, M
    BLOOD, 2002, 100 (11) : 770A - 770A
  • [7] Natural History of Asymptomatic IgM Monoclonal Gammopathies: Impact of the Bone Marrow Aspiration into the Classification and Prognosis
    Fernandez de Larrea, Carlos
    Moreno, David
    Tovar, Natalia
    Teresa Cibeira, Maria
    Isola, Ignacio
    Magnano, Laura
    Rosinol, Laura
    Blade, Joan
    BLOOD, 2018, 132
  • [8] MULTIPLE COMPLICATIONS OF IGM MONOCLONAL GAMMOPATHY
    SOUBRIER, M
    DUBOST, JJ
    JOUANEL, P
    TRIDON, A
    FLORI, B
    LEGUILLE, C
    RISTORI, JM
    BUSSIERE, JL
    REVUE DE MEDECINE INTERNE, 1994, 15 (07): : 484 - 486
  • [9] Monoclonal gammopathy: natural history studied with a retrospective approach
    Steingrimsdottir, Hlif
    Haraldsdottir, Vilhelmina
    Olafsson, Isleifur
    Gudnason, Vilmundur
    Ogmundsdottir, Helga M.
    HAEMATOLOGICA, 2007, 92 (08) : 1131 - 1134
  • [10] Rituximab for polyneuropathy with IgM monoclonal gammopathy
    Niermeijer, J. M. F.
    Eurelings, M.
    Lokhorst, H. L.
    van der Pol, W-L
    Franssen, H.
    Wokke, J. H. J.
    Notermans, N. C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (09): : 1036 - 1039
12345